Live data · NADAC + Part D CY24 · reviewed daily

Clindamycin and Benzoyl Peroxide (Acanya)

First FDA approval2009-08-25
Generic availableNo (brand-only)
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.411/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.660
Across all dosage forms in distribution.
Highest NADAC
$1.13
Range is tight.
Plans with PA
0 / 329
Zero PA friction across surveyed plans.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Clindamycin and Benzoyl Peroxide used for?

Clindamycin and Benzoyl Peroxide is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Clindamycin and Benzoyl Peroxide?

No. Clindamycin and Benzoyl Peroxide is brand-only with no generic equivalents currently in market.

How much does my plan pay for Clindamycin and Benzoyl Peroxide?

Across 329 Part D plans, Clindamycin and Benzoyl Peroxide averages $0.660/unit (NADAC). Lowest available: $0.411/unit. Highest in distribution: $1.13/unit.

Is Clindamycin and Benzoyl Peroxide on the FDA shortage list?

Clindamycin and Benzoyl Peroxide has been discontinued by its manufacturer(s).

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.